These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15109024)

  • 1. Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.
    DiFeo TJ
    Drug Dev Ind Pharm; 2004 Mar; 30(3):247-57. PubMed ID: 15109024
    [No Abstract]   [Full Text] [Related]  

  • 2. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less is more: the human microdosing concept.
    Garner RC
    Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185
    [No Abstract]   [Full Text] [Related]  

  • 4. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preface to Volume 40.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():ix-xii. PubMed ID: 26051691
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical Report No. 38. Manufacturing chromatography systems postapproval changes (ChromPAC): chemistry, manufacturing, and controls documentation.
    PDA Manufacturing Chromatography Systems PAC Taskforce
    PDA J Pharm Sci Technol; 2006 Mar; 60(1 Suppl TR38):1-29. PubMed ID: 16696189
    [No Abstract]   [Full Text] [Related]  

  • 9. A continuous manufacturing concept for a pharmaceutical oral suspension.
    Bostijn N; Van Renterghem J; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2018 Oct; 123():576-583. PubMed ID: 30102980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central role of chemistry in 'quality by design' approaches to drug development.
    Grewal NK; Leadbeater NE
    Future Med Chem; 2012 Sep; 4(14):1799-810. PubMed ID: 23043477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle Engineering Via Mechanical Dry Coating in the Design of Pharmaceutical Solid Dosage Forms.
    Qu L; Morton DA; Zhou QT
    Curr Pharm Des; 2015; 21(40):5802-14. PubMed ID: 26446461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
    Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
    Tsong Y; Yang H
    J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
    [No Abstract]   [Full Text] [Related]  

  • 15. Preface to Volume 43.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2018; 43():ix. PubMed ID: 29678265
    [No Abstract]   [Full Text] [Related]  

  • 16. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical stability of amorphous acetanilide derivatives improved by polymer excipients.
    Miyazaki T; Yoshioka S; Aso Y
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1207-10. PubMed ID: 16880672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAT for tableting: inline monitoring of API and excipients via NIR spectroscopy.
    Wahl PR; Fruhmann G; Sacher S; Straka G; Sowinski S; Khinast JG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):271-8. PubMed ID: 24705126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products.
    Troiano G; Nolan J; Parsons D; Van Geen Hoven C; Zale S
    AAPS J; 2016 Nov; 18(6):1354-1365. PubMed ID: 27631558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.